A critical advance in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently inactivated in several forms of tumors, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research